Recent Finacing
Recent Raise
Ochre Bio develops RNA therapeutics for chronic liver disease using deep phenotyping and spatial single-cell genomics, in silico liver models, a GalNAc-siRNA platform, and ex‑vivo donor liver testing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
